Angiodynamics Stock Alpha and Beta Analysis
| ANGO Stock | USD 9.92 0.05 0.51% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as AngioDynamics. It also helps investors analyze the systematic and unsystematic risks associated with investing in AngioDynamics over a specified time horizon. Remember, high AngioDynamics' alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to AngioDynamics' market risk premium analysis include:
Beta (1.83) | Alpha 0.0379 | Risk 5.8 | Sharpe Ratio 0.0571 | Expected Return 0.33 |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
AngioDynamics |
AngioDynamics Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. AngioDynamics market risk premium is the additional return an investor will receive from holding AngioDynamics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in AngioDynamics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate AngioDynamics' performance over market.| α | 0.04 | β | -1.83 |
AngioDynamics expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of AngioDynamics' Buy-and-hold return. Our buy-and-hold chart shows how AngioDynamics performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.AngioDynamics Market Price Analysis
Market price analysis indicators help investors to evaluate how AngioDynamics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading AngioDynamics shares will generate the highest return on investment. By understating and applying AngioDynamics stock market price indicators, traders can identify AngioDynamics position entry and exit signals to maximize returns.
AngioDynamics Return and Market Media
The median price of AngioDynamics for the period between Sat, Dec 21, 2024 and Fri, Mar 21, 2025 is 9.61 with a coefficient of variation of 13.03. The daily time series for the period is distributed with a sample standard deviation of 1.34, arithmetic mean of 10.27, and mean deviation of 1.17. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Acquisition by Laura Piccinini of 21971 shares of AngioDynamics subject to Rule 16b-3 | 12/20/2024 |
2 | AngioDynamics, Inc.s Share Price Boosted 38 percent But Its Business Prospects Need A Lift Too - Simply Wall St | 01/30/2025 |
3 | AngioDynamics, Inc. Short Interest Down 11.8 percent in January - MarketBeat | 01/31/2025 |
4 | Acquisition by Auen Eileen Oshea of 20541 shares of AngioDynamics subject to Rule 16b-3 | 02/06/2025 |
5 | AngioDynamics Down 14.2 percent Since Last Earnings Report Can It Rebound | 02/07/2025 |
6 | Systematic Financial Management LP Increases Stake in AngioDynamics Inc | 02/13/2025 |
7 | Investors might be losing patience for AngioDynamics increasing losses, as stock sheds 12 percent over the past week | 02/27/2025 |
8 | The Cooper Companies Matches Q1 Earnings Estimates | 03/06/2025 |
9 | Acquisition by James Clemmer of 207693 shares of AngioDynamics at 7.4 subject to Rule 16b-3 | 03/07/2025 |
10 | AngioDynamics to Present at the Oppenheimer 35th Annual Healthcare MedTech and Services Virtual Conference | 03/10/2025 |
11 | Acquisition by Warren Nighan of 5677 shares of AngioDynamics subject to Rule 16b-3 | 03/14/2025 |
About AngioDynamics Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including AngioDynamics or other stocks. Alpha measures the amount that position in AngioDynamics has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2022 | 2023 | 2024 | 2025 (projected) | |
| Days Sales Outstanding | 56.92 | 52.38 | 60.23 | 68.02 |
| PTB Ratio | 0.99 | 1.23 | 1.11 | 1.17 |
AngioDynamics Upcoming Company Events
As portrayed in its financial statements, the presentation of AngioDynamics' financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, AngioDynamics' leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of AngioDynamics' public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of AngioDynamics. Please utilize our Beneish M Score to check the likelihood of AngioDynamics' management manipulating its earnings.
| 4th of April 2024 Upcoming Quarterly Report | View | |
| 10th of July 2024 Next Financial Report | View | |
| 29th of February 2024 Next Fiscal Quarter End | View | |
| 10th of July 2024 Next Fiscal Year End | View | |
| 30th of November 2023 Last Quarter Report | View | |
| 31st of May 2023 Last Financial Announcement | View |
Build Portfolio with AngioDynamics
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out AngioDynamics Backtesting, AngioDynamics Valuation, AngioDynamics Correlation, AngioDynamics Hype Analysis, AngioDynamics Volatility, AngioDynamics History and analyze AngioDynamics Performance. To learn how to invest in AngioDynamics Stock, please use our How to Invest in AngioDynamics guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
AngioDynamics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.